| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3944254 | Gynecologic Oncology | 2009 | 5 Pages |
Abstract
Although BOT has an excellent prognosis, they are not exempted from a risk of recurrence. Stage II/III (or invasive implants), cystectomy and higher pre-operative serum CA-125 were independent variables predicting recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Tzu-I Wu, Chyi-Long Lee, Meng-Yu Wu, Swei Hsueh, Kuan-Gen Huang, Chi-Ju Yeh, Chyong-Huey Lai,